Wed, Apr 16, 2014, 3:30 AM EDT - U.S. Markets open in 6 hrs.

Recent

% | $
Quotes you view appear here for quick access.

Star Scientific, Inc. (CIGX) Message Board

chipper4747 99 posts  |  Last Activity: Apr 7, 2014 11:49 PM Member since: Jun 22, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • chipper4747 chipper4747 Jan 16, 2014 9:53 AM Flag

    Precisely my question and concern, rick. Then the question also becomes: how would current customers gain access to Abloc?

    I suspected some time ago that the injectable version was the key to getting doctors onboard with Abloc: that trials were necessary to proving its success in treating various conditions. The path forward is a lot more clear today than yesterday.

  • Reply to

    Discontinue marketing or discontinue selling?

    by rick3568 Jan 16, 2014 9:22 AM
    chipper4747 chipper4747 Jan 16, 2014 9:56 AM Flag

    I think he did mean marketing, not selling, which would entail keeping the product on the shelves so that current customers can maintain access. The company would end up saving a lot in marketing expenses!

  • chipper4747 chipper4747 Jan 17, 2014 1:23 AM Flag

    "... when Star receives a letter from the FDA demanding they withdraw their products."

    Billyburgerstein,
    Your compadre, nomo, claims this has already happened, and that the products will be removed from the GNC shelves. Don't you guys talk to each other?

  • Let me weigh in here with one more line of thinking as to why this merger makes sense:

    1) Dr. Mullan is a principle in both companies (i.e., he has sway at both companies).

    2) Archer is nearing an end to its Phase 3 trial of Nilvadipine in 500 patients in 9 European countries.

    3) Mullan and associates at Roskamp have confidence in Nilvadipine's ability to block the production of amyloid proteins linked to Alzheimer's disease.

    4) Mullan and others at RCP believe that anatabine might also play well at inhibiting the production of amyloid proteins, thus initial trials are underway to study that potential cause-and-effect.

    5) With a successful Phase 3 trial, Roskamp/Archer might very well want to commercialize Nilvadipine on their own, without partnering with a big pharma company.

    6) Being a private venture, Archer would need to execute an IPO to go public and raise funds for commercialization purposes.

    7) A much simpler and quicker way to "go private" is to merge with RCP, a public company that is also investigating Alzheimer's (and other maladies) treatments using anatabine. One way to look at this merger is the combining of a private company with a "shell company" (RCP), which can issue new shares as part of the merger, and thus raise funds for commercialization.

    8) The combined company would be valued based on the combined potentialities of Nilvadipine, anatabine and other drugs (if any) in the Archer pipeline.

    To me, it is a logical fit in terms of the goals of both companies, it would satisfy the need for Archer to go public and raise funds for selling what could become the world's first true Alzheimer's depressant drug, if eventually approved by the FDA.

    Speaking of the FDA, this dust-up over the selling of Abloc is a minor fly in the ointment, particularly when you look at the opportunities outlined above. RCP does not want a black eye with the FDA, given the possible submission of future NDAs coming down the pike (Nilvadipine, anatabine, etc.).

  • Reply to

    FDA nixes a path breaking drug

    by bhp1rtp Jan 17, 2014 12:50 PM
    chipper4747 chipper4747 Jan 17, 2014 1:09 PM Flag

    IMO the FDA is controlled by big pharma companies, who want to see their profits protected from upstart drugs, and doctor organizations, who don't want to see any less of a need for their members' services.

    Take a look at Vascepa from AMRN, where the FDA in October revoked an agreement that guaranteed that the design of a late-stage trial of Vascepa was adequate to support a marketing application. Instead, the FDA insists on seeing a very broad and expensive and time-consuming heart study. A total change in focus mid-stream.

    There are many other cases where FDA panel members seem to be bought and paid for by outside companies, rather than behaving in an objective, patient-focused manner. This agency needs an enema.

  • Reply to

    Stop Blamming FDA and Look at STAR...

    by freepngnow Jan 17, 2014 2:28 PM
    chipper4747 chipper4747 Jan 19, 2014 1:57 AM Flag

    " And it is very clear that STAR did not follow instructions and that is the reason STAR will have to pull this product."

    Once again, stating an opinion as fact. You shorts have a proclivity for telling lies that removes any credibility that you might wish to exude. Talk to nomo about this. (Or perhaps you have, which is where you came up with your "fact").

  • Reply to

    Stop Blamming FDA and Look at STAR...

    by freepngnow Jan 17, 2014 2:28 PM
    chipper4747 chipper4747 Jan 19, 2014 1:59 AM Flag

    "STAR has not sold $2 million of ABLOC yet... ask chipper."

    steverino,
    Why are you telling lies? You know quite well that Abloc easily sells over $1M per quarter. Thus $2M total was surpassed a long time ago.

    Pathetic.

  • chipper4747 chipper4747 Jan 19, 2014 2:12 AM Flag

    "there is NOT one shred of evidence that STAR will partner with anyone."

    Looks like the B-team (or the C-team, now that I think about it) has arrived to put up their absurd posts. Like this one by steverino (aka nomo). There have been excellent posts outlining rationales for a merger. I have not seen any refutation of such posts by the shorts, except this kind of nonsense.

    {Note to readers of this board: did you notice the period of silence by the shorts lately? This was to huddle up and determine their new course of attack after the 15 Jan CC. They weren't quite sure how to take this talk of a merger, and whether they should be afraid or not. Now they have flocked back to the board to spew their "merger ain't gonna happen" #$%$, which tells me they are very much afraid of this quite possible occurrence. Try a refutation of my post or that of repo_man or that of nerdy_kid if you want folks to pay attention to you.]

  • chipper4747 chipper4747 Jan 19, 2014 2:17 AM Flag

    "How about this; Mullan has taken these CEO positions because he is playing many hands. He is hoping to make it rich by any one of these plays, and he will not merge anything to decrease his chances of success with any one of his companies."

    bdmacg,
    How about that? Nope, doesn't make sense. The boards of the two companies would not let him fly solo in each without looking at the combined savings to be had with the merger of the two. You are looking at it from the perspective of one man. That is not how business is conducted when there are others (BODs) involved. The two companies (RCP and Archer) are NOT his play toys.
    Your logic fails. Again.

  • Reply to

    Interesting take from I-Hub Board

    by nextwave777 Jan 18, 2014 7:27 PM
    chipper4747 chipper4747 Jan 20, 2014 2:51 AM Flag

    " There are over 324,677 transactions per day and you can tell which ones are short and which ones are long?"

    steverino (aka nomo),
    You betcha you can! If you have access to the trade-by-trade data stream, the market maker certainly knows which trades are longs vice shorts. Daily reports from several sites show the total volume of shares traded short vice long (which is all you need to know anyway).
    At least in this regard the SEC has made the markets 'transparent'. But as others have noted in this thread, shorts often "roll over" their short positions before the clock runs out on them having to cover their short trades. In this way, they persistently remain short (and in the dark).

    There is much truth in what nextwave777 wrote. Whether that scenario continues to be in play here will be seen if and when a merger takes place, at which point all RCP shares will be called in to exchange for new shares in the combined company. THAT day would be the shorts' comeuppance.

  • chipper4747 chipper4747 Jan 23, 2014 3:37 AM Flag

    Hey there, nerdy_kid---
    You're absolutely correct that I omitted "reduction in overhead" costs from my list of reasons why an Archer merger makes sense. That item is always a reason listed for any merger, and for me it was a "given", believing that everyone would know that. But you are right -- it deserved to be mentioned, and I thank you for doing so.

  • chipper4747 by chipper4747 Jan 23, 2014 3:50 AM Flag

    After reading the criminal indictment of the ex-governor of VA (and his wife), I realized that JW and --- by extension --- the STSI shareholders were robbed by McDonnell! They kept pushing for items to make them seem more well off than they were, so they could hang with the rest of the republican 1% crowd and fit in nicely. I thought his wife pushing to have JW buy an engraved Rolex was just too precious.

    So what did we get for all of the lavished gifts from JW? SQUAT! Where were all of these VA university studies that the governor said he would help with? Why wasn't VA actively buying Abloc for its government health plan? Geeeeeez!! JW was lousy as a CEO and even worse as a briber. The company got stiffed. So glad JW has for all intents and purposes exited the company.

    New year. New CEO. Company's product made news on several news cable channels that I watched. It was shrouded in a scandal, but the product itself was not labeled as a fraud or something to run away from. Neither was there a ringing endorsement of it. In this case, any publicity does seem to be good publicity. At least now when you ask someone if they use Abloc, they'll know what you're talking about.

    And through all of this, I have yet to see any charges against JW. He was just doing what any well-to-do political donor does these days: he donates! I just wish he had bribed somebody who could have pulled some bigger strings on behalf of the company.

    I need a shower after reading that indictment. But I must say it feels "exciting" to be part of the American political process.

  • Reply to

    We Wuz Robbed!!

    by chipper4747 Jan 23, 2014 3:50 AM
    chipper4747 chipper4747 Jan 24, 2014 3:28 AM Flag

    " so I hope you get out with a profit or are at least not hurt terribly"

    Rick,
    Thanks for the sentiment and your opinions on this scandal. i agree with just about everything you wrote. Where I indicated that "any publicity is good publicity" (and you disagreed), my thinking was simply that a) more people have heard about the product, and b) if they know others who take it (and like it), it'll be an easier sell to the newcomer. But I also have to agree with you that some folks won't want to buy a product that is at the heart of this scandal.
    I have not been terribly hurt by this decline in pps, primarily because all the shares I have are locked away in an IRA and my thesis has not changed, although the timing of events has been shuffled. My next post will identify what I think are the near-term issues to be solved for the company to move ahead.

  • chipper4747 by chipper4747 Jan 24, 2014 3:41 AM Flag

    The company has a lot of homework to do before it can focus on the prize ahead of it. The checklist, as I see it, is as follows:

    1) Move to Florida. (Start selling Abloc on street corners in retirement communities.)

    2) Resolve the FDA warning letter issues. (Make sure no undue promises are made on the bottle, web site or in advertising).

    3) Merge with Archer and execute a name change. (I doubt a name change will occur before the merger. I give the odds of a merger at roughly 3:1 (70-75% chance of it happening). The timing, though, will have to wait until the FDA issue is resolved.)

    4) Conduct a more extensive CC around the time of the next earnings release. (The investors are starved for info on the company's plans for getting Abloc into new venues and markets.)

    5) Give an overview of the company's finances and any need for issuance of new shares. (Would be helpful at the same time to discuss if the company is targeting the illegal naked shorting occurring with its stock).

    6) Give an overview of ongoing studies and upcoming publications in journals.

    That's plenty to do for the next few months. No matter what the shorts think, Abloc is not going away.

  • Reply to

    Moving forward from here

    by chipper4747 Jan 24, 2014 3:41 AM
    chipper4747 chipper4747 Jan 25, 2014 4:00 AM Flag

    " It's been a train wreck in case you didn't notice."

    I prefer train wrecks to airplane crashes. Fewer issues to resolve, clear the tracks, upright any cars off the rails, and continue down the track. Completely recoverable.

    Airplane crashes are unrecoverable. Everyone dies, everything smashed to smithereens.

    I don't see many shorts saying that Abloc will be pulled from the market place, despite your assertion that it will indeed happen with 100% probability. You want train wrecks? Look at your own posts for unrecoverable mistakes.

  • Reply to

    Moving forward from here

    by chipper4747 Jan 24, 2014 3:41 AM
    chipper4747 chipper4747 Jan 28, 2014 3:33 AM Flag

    "You must have missed the Harvard expert quoted as saying that pulling of ABloc is exactly what will happen"

    Well, nomo, are you still trying to turn your "Abloc will be pulled" lie into something you hope will make it come true? By relying on a hack Harvard activist who, in my view, would like all supplements pulled?

    Yep, nomo, I did indeed miss that. And for good reason. Next!

  • Reply to

    Chippy, the boy who cried wolf?

    by stsinomo Jan 14, 2014 10:48 AM
    chipper4747 chipper4747 Jan 28, 2014 3:42 AM Flag

    I'm just the one who cried "Liar!!", when you flat out stated that Abloc would be pulled from GNC. And if that isn't discussing STSI, then what is? Yet another lie, nomo?

    It's really funny that you can't even publish a smear post without injecting yet more lies into it. I guess lying is just in your nature.

    And yes, I did call you a coward.... and I still do! Where's the $100 bet you AREN'T willing to put up to stand behind your claim that Abloc will be pulled?

    Coward and a liar, all wrapped into one human being. I can smell you from here.

  • Reply to

    Well

    by rick3568 Jan 27, 2014 4:15 PM
    chipper4747 chipper4747 Jan 28, 2014 3:57 AM Flag

    "If the answer to the question is simply "Im holding for long term" then just know you could be looking at a value of 50 cents or who knows even 25 cents a share and YEARS before it recaptures value. You could also lose your entire investment."

    Well Rick, it seems you're quite the bi-polar investor, aren't you? I've seen this from you before, well every post was in support of the short side. Is your sudden panic attack all based on a drop in price, which in turn was helped along by a non-scientific article that said "SELL!"? Is this the reaction I am seeing from you? Is the short side where you reside these days?

    But I will answer the question above, as I believe it deserves an answer. And my answer is based on a recent thread I wrote that outlined what I thought were the next steps/issues the company had to achieve in order to move down the tracks. One of the first ones was the move to Florida, which I would imagine is either underway or in the planning stage. The other, of course, is a reply to the FDA, in conjunction with purifying their Abloc advertising and web site so that it doesn't violate any FDA regs.

    I expected some kind of negative karma as a result of the adverse publicity due to the McDonnell scandal. But I didn't expect (but perhaps should have) that another shallow hit piece on the company would come out as a last gasp effort to make hay of the McDonnell affair. I doubt that Mullan will issue a PR to respond to the hit piece, as that would set a bad precedent.

    So, Rick, you either believe in the science and the new management and its vision/plans, or you don't (and sell your stock). Why bellyache here instead of just selling out and joining a new stock board? Abloc still works wonders for myself and those I know who take it. There is value there. I will not be selling unless my thesis no longer holds. And nothing I read today (nor a price drop) has invalidated it.

    Good luck to you.

  • chipper4747 chipper4747 Jan 29, 2014 3:39 AM Flag

    "I found the article and it says the state investigation has been ongoing since Nov 2012 ???

    But no charges were filed ???"

    Easy simple answer: During the time ("since Nov 2012") of the investigation, the republicans were in charge of both the VA House and Senate. Therefore, even though they may have felt compelled to investigate (since accusations were made against the governor), they did not report out in order not to embarrass one of their own. If they had found no wrongdoing of state laws, I would imagine they would have made their findings public.

    Now, though, the VA Senate has changed hands over to the democrats. I'm guessing the federal investigation will take precedence over the state's.

  • Reply to

    Short Memories?

    by uptick77777 Jan 28, 2014 3:08 PM
    chipper4747 chipper4747 Jan 29, 2014 3:48 AM Flag

    Thanks for the walk down memory lane (all of 9 days ago). In fact, I had forgotten that post myself, not that it influences my thesis one way or another. But it is a balance against the short attack article(s) now circulating.

STSI
0.7807+0.0417(+5.64%)Apr 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.